| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK4112 |
|---|
| Description | A synthetic agonist for REV-ERBα (EC50 = 0.4 μM) that mimics the action of heme; at 10 μM inhibits the expression of the circadian target gene bmal1 and reduces glucose output by 30% in mouse primary hepatocytes by repressing the expression of several gluconeogenic genes |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | REV-ERBα nuclear hormone receptors circadian rhythm adipogenesis lipids metabolisms inflammation hemes NCoR HDAC3 transcriptional repression agonists gluconeogenesis GSK 4112 REVERBα inhibits inhibitors inhibiting bmal1 ovaries metabolism |
|---|
| Gene, Accession, CAS # | CAS: 1216744-19-2 |
|---|
| Catalog # | 11931-50 |
|---|
| Price | |
|---|
| Order / More Info | GSK4112 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|